Literature DB >> 33947769

Factors influencing thrombectomy decision making for primary medium vessel occlusion stroke.

Petra Cimflova1,2, Manon Kappelhof3,4, Nishita Singh1, Nima Kashani4,5, Johanna Maria Ospel6, Rosalie McDonough4,7, Andrew M Demchuk1,8, Bijoy K Menon1, Nobuyuki Sakai9, Michael Chen10, Jens Fiehler7, Mayank Goyal11.   

Abstract

BACKGROUND: We aimed to explore the preference of stroke physicians to treat patients with primary medium vessel occlusion (MeVO) stroke with immediate endovascular treatment (EVT) in an international cross-sectional survey, as there is no clear guideline recommendation for EVT in these patients.
METHODS: In the survey MeVO-Finding Rationales and Objectifying New Targets for IntervEntional Revascularization in Stroke (MeVO-FRONTIERS), participants were shown four cases of primary MeVOs (six scenarios per case) and asked whether they would treat those patients with EVT. Multivariable logistic regression with clustering by respondent was performed to assess factors influencing the decision to treat. Dominance analysis was performed to assess the influence of factors within the scenarios on decision making.
RESULTS: Overall, 366 participants (56 women; 15%) from 44 countries provided 8784 answers to 24 scenarios. Most physicians (59.2%) would treat patients immediately with EVT. Younger patient age (incidence rate ratio (IRR) 1.24, 99% CI 1.19 to 1.30), higher National Institutes of Health Stroke Scale (NIHSS) score (IRR 1.69, 99% CI 1.57 to 1.82), and small core volume (IRR 1.35, 99% CI 1.24 to 1.46) were positively associated with the decision to treat with EVT. Interventionalists (IRR 1.26, 99% CI 1.01 to 1.56) were more likely to treat patients with MeVO immediately with EVT. In the dominance analysis, factors influencing the decision in favor of EVT were (in order of importance): baseline NIHSS, core volume, alteplase use, patients' age, and occlusion site.
CONCLUSIONS: Most physicians in this survey were interventionalists and would treat patients with MeVO stroke immediately with EVT. This finding supports the need for robust clinical evidence. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  intervention; stroke; thrombectomy

Mesh:

Year:  2021        PMID: 33947769     DOI: 10.1136/neurintsurg-2021-017472

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  3 in total

1.  Interrater Agreement and Detection Accuracy for Medium-Vessel Occlusions Using Single-Phase and Multiphase CT Angiography.

Authors:  J M Ospel; F Bala; R V McDonough; O Volny; N Kashani; W Qiu; B K Menon; M Goyal
Journal:  AJNR Am J Neuroradiol       Date:  2021-11-25       Impact factor: 3.825

2.  Worldwide anaesthesia use during endovascular treatment for medium vessel occlusion stroke.

Authors:  Manon Kappelhof; Johanna M Ospel; Petra Cimflova; Nima Kashani; Nishita Singh; Rosalie McDonough; Arshia Sehgal; Mohammed A Almekhlafi; Jens Fiehler; Michael Chen; Nobuyuki Sakai; Charles Blm Majoie; Mayank Goyal
Journal:  Interv Neuroradiol       Date:  2021-10-19       Impact factor: 1.764

3.  Middle Cerebral Artery M2 Thrombectomy: Safety and Technical Considerations in the German Stroke Registry (GSR).

Authors:  Moriz Herzberg; Franziska Dorn; Christoph Trumm; Lars Kellert; Steffen Tiedt; Katharina Feil; Clemens Küpper; Frank Wollenweber; Thomas Liebig; Hanna Zimmermann
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.